BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 14594906)

  • 1. Drug induced QT prolongation and torsades de pointes.
    Yap YG; Camm AJ
    Heart; 2003 Nov; 89(11):1363-72. PubMed ID: 14594906
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.
    Yap YG; Camm J
    BMJ; 2000 Apr; 320(7243):1158-9. PubMed ID: 10784527
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced QT prolongation and sudden death.
    Del Rosario ME; Weachter R; Flaker GC
    Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    Hsieh MH; Chen SA; Chiang CE; Tai CT; Lee SH; Wen ZC; Chang MS
    Int J Cardiol; 1996 Apr; 54(1):85-8. PubMed ID: 8792191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced QT prolongation.
    Michowitz MK; Michowitz Y; Zaidenstien R; Golik A
    Isr Med Assoc J; 2000 Dec; 2(12):924-8. PubMed ID: 11344777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long QT-syndrome as a drug-induced side effect].
    Pohjola-Sintonen S
    Duodecim; 1998; 114(19):1891, 1893, 1895. PubMed ID: 11717743
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
    De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
    Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced q-T prolongation.
    Kao LW; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
    Wolbrette DL
    Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced QT prolongation.
    Tzivoni D
    Isr Med Assoc J; 2001 Jun; 3(6):472. PubMed ID: 11433657
    [No Abstract]   [Full Text] [Related]  

  • 13. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced cardiac arrest maybe more common than believed].
    Abdon NJ; Herlitz J; Bergfeldt L
    Lakartidningen; 2010 Feb 24-Mar 2; 107(8):521-2, 524-5. PubMed ID: 20384063
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians.
    Heist EK; Ruskin JN
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S1-8. PubMed ID: 16253926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
    Sugiyama A
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):393-400. PubMed ID: 12835533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.
    Letsas KP; Efremidis M; Kounas SP; Pappas LK; Gavrielatos G; Alexanian IP; Dimopoulos NP; Filippatos GS; Sideris A; Kardaras F
    Clin Res Cardiol; 2009 Apr; 98(4):208-12. PubMed ID: 19031039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).
    Ritter JM
    Br J Clin Pharmacol; 2012 Mar; 73(3):331-4. PubMed ID: 22329611
    [No Abstract]   [Full Text] [Related]  

  • 20. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.
    Cubeddu LX
    Am J Ther; 2003; 10(6):452-7. PubMed ID: 14624285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.